Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › N Hollywood › NPI 1891873303
Lab

Southern California Permanente Medical Group

Southern California Permanente Medical Group was paid $63.44M by Medicaid between Jan 2018 and Dec 2024, across 380 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 6.2% of everything it billed.

33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
N HOLLYWOOD, CA 91605
33aNPI1891873303assigned 11/01/2006
33bProvider typeClinical Medical Laboratory
28Total paid$63.44M
24GClaims6,517,662
24DCodes billed380
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#15 of 561
Median peer was paid$222K
This provider vs. median286×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018471,522$53K
2019653,985$435K
2020616,987$5.66M
2021845,899$8.34M
20221,064,164$11.61M
20231,313,947$15.83M
2024incomplete1,551,158$21.52M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 6.2% 222,523 221,143 $3.96M
83036 Hemoglobin; glycosylated (A1C) 6.2% 449,613 445,356 $3.92M
84443 Thyroid stimulating hormone (TSH) 5.0% 256,954 254,061 $3.15M
80061 Lipid panel 4.8% 283,041 281,637 $3.08M
88305 Level IV - Surgical pathology, gross and microscopic examination 4.1% 99,076 70,022 $2.61M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.6% 110,609 105,904 $2.30M
82565 3.2% 352,850 344,447 $2.01M
80051 2.8% 243,048 237,491 $1.77M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.7% 41,618 33,363 $1.71M
81513 2.6% 50,255 48,520 $1.62M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.2% 153,405 153,247 $1.41M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.2% 151,036 139,661 $1.41M
368 more codes
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.2% 150,760 $1.41M
83970 2.0% 24,603 $1.27M
82274 2.0% 108,531 $1.27M
84460 2.0% 263,702 $1.26M
86480 1.5% 33,454 $977K
87088 1.5% 168,017 $950K
82607 1.4% 59,348 $879K
82043 1.4% 120,532 $878K
86003 1.3% 57,627 $843K
82728 1.3% 74,476 $838K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.3% 50,069 $825K
87481 1.3% 49,806 $823K
84153 1.1% 34,368 $715K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.1% 87,813 $712K
87505 <1% 7,846 $605K
84165 <1% 17,531 $604K
83520 <1% 30,573 $555K
83550 <1% 77,355 $534K
88173 <1% 9,615 $524K
84439 <1% 75,971 $514K
86803 <1% 73,844 $510K
86780 <1% 95,729 $473K
82784 <1% 36,934 $456K
86334 <1% 9,431 $452K
82310 <1% 63,195 $433K
88341 <1% 3,616 $426K
88342 <1% 6,657 $417K
82746 <1% 28,141 $415K
88360 <1% 3,516 $414K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 109,205 $410K
83540 <1% 78,563 $378K
84403 <1% 26,206 $340K
87186 <1% 45,769 $337K
84450 <1% 74,110 $327K
86335 <1% 5,346 $313K
84075 <1% 58,888 $294K
84520 <1% 67,593 $274K
86256 <1% 9,611 $263K
82247 <1% 57,124 $263K
87340 <1% 68,399 $259K
83721 <1% 33,602 $254K
80197 <1% 16,530 $248K
82040 <1% 43,590 $241K
87799 <1% 7,166 $238K
87536 <1% 3,843 $237K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,950 $233K
88112 <1% 6,577 $227K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 16,344 $217K
82947 <1% 76,070 $208K
83735 <1% 31,748 $206K
88312 <1% 3,068 $189K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,893 $184K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 26,508 $178K
86141 <1% 14,711 $174K
86160 <1% 12,306 $154K
84146 <1% 23,906 $151K
86235 <1% 10,257 $145K
87522 Neg quan hep c or qual rna <1% 4,842 $144K
86255 <1% 9,320 $142K
84132 <1% 30,278 $141K
87529 <1% 9,597 $139K
83718 <1% 24,690 $127K
86038 <1% 22,508 $126K
88185 <1% 250 $124K
84100 <1% 22,594 $114K
82378 <1% 5,204 $112K
87338 <1% 59,929 $111K
86635 <1% 15,065 $109K
82105 <1% 5,786 $105K
82670 <1% 15,676 $104K
87070 <1% 19,010 $99K
87497 <1% 1,867 $98K
86146 <1% 2,871 $98K
86317 <1% 18,046 $96K
88304 <1% 5,297 $95K
83655 <1% 81,693 $95K
84134 <1% 5,366 $90K
86704 <1% 11,510 $87K
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician <1% 20,110 $85K
83021 <1% 19,321 $84K
83001 <1% 14,544 $84K
86147 <1% 3,833 $82K
84295 <1% 15,511 $77K
84480 <1% 11,107 $76K
84425 <1% 6,018 $73K
84166 <1% 1,131 $71K
86225 <1% 10,216 $70K
87081 <1% 62,577 $69K
84270 <1% 7,029 $67K
83993 <1% 8,084 $67K
82465 <1% 26,458 $66K
87449 <1% 10,141 $64K
86304 <1% 3,093 $61K
87517 <1% 1,397 $60K
88313 <1% 541 $59K
84550 <1% 15,365 $58K
82248 <1% 12,512 $57K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 632 $56K
86376 <1% 8,600 $54K
83002 <1% 13,845 $53K
86364 <1% 6,750 $51K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 14,240 $49K
82533 <1% 4,679 $48K
87116 <1% 4,740 $48K
88141 <1% 6,341 $48K
87040 <1% 6,650 $45K
88307 <1% 376 $43K
86762 <1% 13,894 $43K
82785 <1% 6,661 $42K
86787 <1% 14,149 $40K
86300 <1% 2,025 $39K
86431 <1% 9,666 $36K
82550 <1% 6,940 $36K
80164 <1% 4,948 $36K
84154 <1% 1,674 $36K
82985 <1% 7,019 $34K
87102 <1% 10,172 $33K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,585 $32K
84432 <1% 2,159 $32K
88184 <1% 255 $31K
82024 <1% 1,212 $31K
82627 <1% 4,115 $30K
83519 <1% 5,628 $30K
80158 <1% 1,870 $30K
86665 <1% 4,452 $30K
86765 <1% 10,232 $29K
86301 <1% 1,167 $29K
83090 <1% 1,547 $28K
87206 <1% 4,678 $27K
88108 <1% 1,289 $27K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,174 $27K
86708 <1% 3,568 $27K
83516 <1% 4,846 $26K
82103 <1% 3,691 $26K
87305 <1% 1,611 $26K
86645 <1% 2,721 $26K
82977 <1% 4,316 $25K
86696 <1% 3,918 $25K
83020 <1% 2,560 $24K
80177 <1% 4,269 $24K
84311 <1% 2,190 $24K
82390 <1% 4,393 $24K
86316 <1% 1,507 $23K
86800 <1% 1,647 $23K
86885 <1% 25,150 $22K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,347 $22K
84445 <1% 4,989 $21K
88142 <1% 3,411 $21K
86709 <1% 3,572 $21K
82653 <1% 1,137 $21K
83880 <1% 272 $20K
87327 <1% 1,482 $20K
86039 <1% 3,358 $19K
86705 <1% 1,123 $19K
82525 <1% 2,811 $19K
86735 <1% 6,331 $19K
86592 <1% 7,810 $19K
84238 <1% 639 $18K
84244 <1% 5,080 $17K
82088 <1% 5,060 $17K
86769 <1% 2,272 $17K
86695 <1% 3,918 $17K
82397 <1% 2,380 $17K
80230 <1% 937 $17K
86341 <1% 3,026 $16K
85613 <1% 3,975 $16K
84478 <1% 2,966 $16K
87385 <1% 882 $15K
87046 <1% 1,923 $15K
84207 <1% 5,594 $15K
84155 <1% 4,342 $14K
84630 <1% 2,336 $14K
83010 <1% 943 $13K
84681 <1% 915 $13K
86664 <1% 2,225 $13K
82570 <1% 5,350 $13K
82610 <1% 1,607 $13K
80356 <1% 4,106 $13K
86900 <1% 24,614 $12K
86901 <1% 24,606 $12K
84144 <1% 1,323 $12K
82150 <1% 3,582 $12K
80373 <1% 4,087 $12K
80195 <1% 1,186 $12K
80354 <1% 4,088 $12K
80358 <1% 4,088 $12K
80372 <1% 4,088 $12K
80365 <1% 4,086 $12K
80361 <1% 5,017 $12K
80324 <1% 3,300 $12K
80359 <1% 3,441 $12K
83498 <1% 9,531 $12K
85730 <1% 4,436 $11K
87147 <1% 4,171 $11K
85306 <1% 1,431 $11K
86340 <1% 1,194 $10K
82340 <1% 4,232 $10K
84305 <1% 7,265 $10K
80175 <1% 3,257 $10K
80349 <1% 1,101 $10K
82164 <1% 927 $10K
84446 <1% 1,686 $9K
85303 <1% 1,381 $9K
87075 <1% 997 $9K
82157 <1% 5,027 $9K
80348 <1% 4,087 $9K
86790 <1% 2,180 $9K
86870 <1% 788 $9K
86606 <1% 400 $8K
86682 <1% 933 $8K
86593 <1% 2,988 $8K
80178 <1% 2,220 $8K
86738 <1% 1,921 $8K
85247 <1% 1,694 $8K
86366 <1% 122 $7K
85300 <1% 1,337 $7K
86812 <1% 3,130 $7K
82705 <1% 1,958 $7K
87185 <1% 3,364 $7K
84590 <1% 5,633 $7K
86618 <1% 1,283 $7K
82668 <1% 1,123 $7K
85246 <1% 844 $6K
82085 <1% 2,830 $6K
86022 <1% 352 $6K
86777 <1% 1,068 $6K
85660 <1% 3,189 $6K
80156 <1% 349 $6K
82365 <1% 851 $6K
86331 <1% 366 $5K
86008 <1% 1,304 $5K
82542 <1% 1,041 $5K
87109 <1% 4,099 $5K
87254 <1% 1,624 $5K
85240 <1% 890 $5K
83986 <1% 3,872 $5K
82523 <1% 549 $5K
86778 <1% 818 $5K
82104 <1% 317 $5K
82530 <1% 387 $5K
82010 <1% 887 $4K
82507 <1% 3,081 $4K
84560 <1% 3,035 $4K
83945 <1% 3,071 $4K
84105 <1% 3,035 $4K
84133 <1% 2,997 $4K
82140 <1% 3,000 $4K
84392 <1% 3,000 $4K
84300 <1% 3,005 $4K
82232 <1% 215 $4K
87496 <1% 197 $4K
82595 <1% 820 $4K
83525 <1% 826 $4K
82787 <1% 152 $4K
84466 <1% 270 $4K
87902 <1% 24 $4K
86021 <1% 630 $4K
86677 <1% 1,987 $4K
87493 <1% 112 $4K
80299 <1% 585 $3K
83835 <1% 834 $3K
86788 <1% 401 $3K
82652 <1% 1,486 $3K
86337 <1% 527 $3K
86753 <1% 319 $3K
80183 <1% 834 $3K
84080 <1% 970 $3K
80321 <1% 791 $3K
86041 <1% 314 $3K
82239 <1% 2,426 $3K
82435 <1% 860 $3K
82656 <1% 616 $2K
80201 <1% 179 $2K
86747 <1% 934 $2K
82384 <1% 297 $2K
82374 <1% 740 $2K
82380 <1% 1,098 $2K
87350 <1% 797 $2K
87255 <1% 3,693 $2K
82960 <1% 521 $2K
80185 <1% 81 $2K
84597 <1% 209 $2K
84702 <1% 210 $2K
86757 <1% 316 $2K
84255 <1% 155 $2K
87899 <1% 56 $2K
86707 <1% 619 $1K
84436 <1% 894 $1K
80180 <1% 175 $1K
86609 <1% 78 $1K
84252 <1% 205 $1K
85245 <1% 300 $1K
86258 <1% 906 $1K
83695 <1% 401 $1K
82941 <1% 242 $1K
82180 <1% 279 $1K
83529 <1% 92 $1K
86698 <1% 154 $1K
83825 <1% 311 $940.53
86711 <1% 78 $809.87
82172 <1% 413 $745.92
86774 <1% 132 $722.34
87535 <1% 52 $720.00
87184 <1% 82 $707.33
80076 <1% 119 $626.32
86702 <1% 74 $621.62
83003 <1% 298 $542.91
87538 <1% 39 $540.00
80048 Basic metabolic panel (calcium, ionized) <1% 86 $534.33
87593 <1% 173 $512.78
87181 <1% 39 $479.80
80346 <1% 133 $462.14
87149 <1% 44 $459.65
86611 <1% 499 $446.62
85670 <1% 743 $392.22
86701 <1% 73 $375.80
86162 <1% 100 $356.13
80159 <1% 30 $351.12
86336 <1% 112 $349.44
84540 <1% 41 $315.00
82308 <1% 46 $289.80
87205 <1% 77 $274.27
86215 <1% 124 $261.84
87103 <1% 12 $257.00
85610 <1% 775 $242.73
84402 <1% 500 $235.00
84143 <1% 90 $225.88
87563 <1% 42 $215.09
82175 <1% 51 $200.68
86612 <1% 26 $168.00
86622 <1% 28 $165.60
84481 <1% 139 $159.26
82077 <1% 14 $151.92
85549 <1% 26 $117.36
86794 <1% 444 $113.11
83497 <1% 143 $101.98
86060 <1% 13 $100.00
87045 <1% 304 $93.60
87425 <1% 79 $79.80
82626 <1% 30 $67.20
82438 <1% 14 $65.40
86886 <1% 62 $61.80
86157 <1% 24 $58.80
82375 <1% 12 $50.40
82042 <1% 13 $32.69
82679 <1% 12 $29.40
3078F 0% 2,539 $0.00
3051F 0% 9,959 $0.00
87329 0% 216 $0.00
87631 0% 166 $0.00
3046F 0% 8,442 $0.00
73630 0% 12 $0.00
85520 0% 12 $0.00
80323 0% 34 $0.00
81003 0% 25 $0.00
73562 0% 14 $0.00
77080 0% 14 $0.00
3074F 0% 2,667 $0.00
3052F 0% 6,146 $0.00
3044F 0% 88,805 $0.00
84591 0% 41 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 125 $0.00
86140 0% 218 $0.00
92227 0% 86 $0.00
85027 0% 27 $0.00
90686 0% 84 $0.00
83921 0% 27 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Same official

Other billing entities under DAVIDOFF, RAMIN

Full network →
ProviderLocationPaid
Southern California Permanente Medical GroupBellflower, CA$52.84M
Southern California Permanente Medical GroupChino Hills, CA$50.89M
Southern California Permanente Medical GroupLos Angeles, CA$48.19M
Southern California Permanente Medical GroupSan Diego, CA$42.84M
Southern California Permanente Medical GroupPanorama City, CA$35.56M
Southern California Permanente Medical GroupFontana, CA$30.65M
Southern California Permanente Medical GroupLos Angeles, CA$29.70M
Southern California Permanente Medical GroupBaldwin Park, CA$27.51M
Southern California Permanente Medical GroupLancaster, CA$25.36M
Southern California Permanente Medical GroupHarbor City, CA$20.06M
Southern California Permanente Medical GroupAnaheim, CA$17.76M
Southern California Permanente Medical GroupRiverside, CA$15.66M
Southern California Permanente Medical GroupWoodland Hills, CA$11.55M
Southern California Permanente Medical GroupBakersfield, CA$6.92M
Southern California Permanente Medical GroupLos Angeles, CA$1.56M
Southern California Permanente Medical GroupSan Diego, CA$196K
Southern California Permanente Medical GroupOxnard, CA$194K
Southern California Permanente Medical GroupHawthorne, CA$113K
Southern California Permanente Medical GroupHemet, CA$101K
Southern California Permanente Medical GroupFontana, CA$77K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.